CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading organization profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Organizations/healthcare

healthcare organization

Centre Hospitalier Universitaire Henri-Mondor

FR

OPENALEX: I3019246885↗ROR: 04m61mj84↗

People

Connected researchers

Andreı̈ SzökeORCID 0000-0003-2973-7981 Antonio LasalviaORCID 0000-0001-9963-6081 Aziz FerchiouORCID 0000-0002-7983-7940 Elles MesschaartExact authorship link Franck SchürhoffORCID 0000-0002-2732-406X Grégoire BaudinORCID 0000-0002-5285-5401 Marion LEBOYERORCID 0000-0001-5473-3697 Stéphane JamainORCID 0000-0002-4321-4100

Public evidence

2 connected articles

Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study.2021 · PubMed Central Open Access The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study.2021 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: OpenAlex.

Centre Hospitalier Universitaire Henri-Mondor - Medical Cannabis Research Engine